Cequa and Dyspnea - a phase IV clinical study of FDA data

Summary:

Dyspnea is reported as a side effect among people who take Cequa (cyclosporine), especially for people who are female, 60+ old, also take Plaquenil, and have Systemic lupus erythematosus.

The phase IV clinical study analyzes which people have Dyspnea when taking Cequa. It is created by eHealthMe based on reports of 1,539 people who have side effects when taking Cequa from the FDA, and is updated regularly.

What is Cequa?

Cequa has active ingredients of cyclosporine. eHealthMe is studying from 1,543 Cequa users. Check the latest studies of Cequa.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,715 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

On Jul, 16, 2026

1,539 people reported to have side effects when taking Cequa.
Among them, 11 people (0.71%) have Dyspnea.

Among these 11 people:

What is the gender of people who have Dyspnea when taking Cequa? *

female: 90 %
male: 10 %

What is the age of people who have Dyspnea when taking Cequa? *

What are other drugs people take besides Cequa? *

What are other side effects people have besides Dyspnea? *

Rashes (redness): 4 people, 36.36%
Fatigue (feeling of tiredness): 4 people, 36.36%
Joint Swelling: 3 people, 27.27%
Peripheral Swelling: 2 people, 18.18%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 2 people, 18.18%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 2 people, 18.18%
Indigestion: 2 people, 18.18%
Dizziness: 2 people, 18.18%
Undifferentiated Connective Tissue Disease: 2 people, 18.18%
Constipation: 2 people, 18.18%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 18.18%
Sleep Disorder: 1 person, 9.09%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 9.09%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 9.09%
Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
Neuralgia (pain in one or more nerves): 1 person, 9.09%
Insomnia (sleeplessness): 1 person, 9.09%
Hereditary Haemorrhagic Telangiectasia (hereditary -development of multiple abnormalities in the blood vessels): 1 person, 9.09%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 1 person, 9.09%
Heart Attack: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cequa and have Dyspnea?

- Check whether Dyspnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cequa:

Cequa (1,543 reports)

Dyspnea treatments and more:

Dyspnea (661,578 reports)

Browse all side effects of Cequa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea:

Dyspnea (3,715 drugs)

Browse all the conditions that are associated with Dyspnea:

Dyspnea (6,067 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Cequa) and Cequa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.